Home › NDC Lookup › Ingredients › Bisacodyl › 57896-0443-01
💊image loading
(from DailyMed)

Bisacodyl 10 mg Suppository, 100 suppositories — NDC 57896-443-01 (Billing 57896-0443-01)

by GERI-CARE PHARMACEUTICAL CORP · 20 BLISTER PACK in 1 CARTON / 5 SUPPOSITORY in 1 BLISTER PACK

This is a package of 100 suppositories of Bisacodyl 10 mg Suppository from GERI-CARE PHARMACEUTICAL CORP, marketed since Nov 2019 and currently FDA-listed. It is the main listing for this product, which comes in 3 package sizes.

NDC 57896-0443-01
🏷️ FDA NDC (as labeled) 57896-443-01 billing pads the product segment with a zero
This package
Contains100 suppositories Pack sizes3 compare ↓
Main listing for product 57896-443 · Also comes in: 12 suppositories 57896-443-12 50 suppositories 57896-443-05
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Past resolved recalls for this product (1)
Class II · Jun 29, 2022 · Terminated — CGMP Deviations: products were stored outside the drug label specifications. (Mckesson Medical-Surgical Inc. Corporate Office) · FDA recall D-1312-2022

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 57896-443-01
Product NDC 57896-443
11-digit billing NDC 57896044301
NCPDP billing unit EA — each (per item)
RxCUI 198509
UNII 10X0709Y6I
UPC 0357896444051
Application # 505G(a)(3)
SPL Set ID a747a57a-028e-70ea-e053-2a95a90ac184
Established class (EPC) Stimulant Laxative
Physiologic effect Increased Large Intestinal Motility; Stimulation Large Intestine Fluid/Electrolyte Secretion
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2019-11-01
Route RECTAL
Dosage form SUPPOSITORY
Substance BISACODYL

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 46200010005205
GPI class Bisacodyl
GCN Seq No 002944
GCN 08731
HICL code 001301
Ingredient (HICL) Bisacodyl
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q3
Therapeutic class — intermediate (HIC2) Anal-Rectal Preparations
HIC3 code Q3S
Therapeutic class — specific (HIC3) Laxatives, Local/Rectal
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name BISACODYL 10 MG SUPPOSITORY
FDB brand name Bisacodyl
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 002944
  • GCN: 08731
  • GPI-14 (Medi-Span): 46200010005205
  • HICL (First Databank): 001301
  • AHFS class code: 56:12.00.00
  • RxCUI (RxNorm): 198509
Why two NDCs? The FDA registers this code as 57896-443-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 57896-0443-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Stimulant Laxative class.

Pharmacologic class Stimulant Laxative
Drug family (ATC) Contact laxatives, Enemas
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name BISACODYL 10 MG SUPPOSITORY Ingredient Bisacodyl
📗 Our plain-language guide HelloPharmacist
  • It relieves occasional constipation and irregularity. The Fleet enema is also used for fecal impaction and to clear residue after a barium test. It is meant for short-term use.
  • It depends on the form. Tablets usually work in 6 to 12 hours. Suppositories usually work in 15 minutes to 1 hour. The Fleet enema usually works in 5 to 20 minutes.
  • Not right away. Wait at least 1 hour after an antacid or milk before taking tablets. Swallow tablets whole with water and do not chew or crush them.
  • Can I take the tablets with an antacid or milk?
📖 Read our full Bisacodyl guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 12 suppositories 50 suppositories
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
57896-0443-01 You're viewing this Main listing 20 BLISTER PACK in 1 CARTON / 5 SUPPOSITORY in 1 BLISTER PACK 2019-11-01 — Active
57896-0443-05 57896-443-05 10 BLISTER PACK in 1 CARTON / 5 SUPPOSITORY in 1 BLISTER PACK 2019-11-01 — Active
57896-0443-12 57896-443-12 2 BLISTER PACK in 1 CARTON / 6 SUPPOSITORY in 1 BLISTER PACK 2019-11-01 — Active

Pack size FAQ

What quantity is in this package?
This package contains 100 suppositories — 20 blister pack in 1 carton / 5 suppository in 1 blister pack.
How does this package differ from NDC 57896-0443-12?
Both are Bisacodyl 10 mg Suppository — the drug itself is identical. This page's package is the 100 suppositories one, while NDC 57896-0443-12 is the 12 suppositories package.
What NDC number is used to bill for this package of Bisacodyl 10 mg Suppository?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Bisacodyl 10 mg 00574-7050-12 Padagis 12 suppositories $0.320 — Availability likely —
Bisacodyl 10 mg 00904-7142-12 Major 12 suppositories $0.320 — Availability likely —
Good Neighbor Pharmacy Gentle Laxative 10 mg/2000mg 46122-0608-51 AmerisourceBergen 40 mg $0.320 — Availability likely —
Bisacodyl 10 mg 57237-0327-03 Rising 30 suppositories $0.320 — Availability likely —
Proctozone-B 10 mg 57237-0337-03 Rising 30 suppositories $0.320 — Availability likely —
Bisacodyl 10 mg 70000-0573-01 Cardinal 4 suppositories $0.320 — Availability likely —
Foster and Thrive Gentle Laxative 10 mg/2000mg 70677-1091-01 Strategic 40 mg $0.320 — Availability likely —
Walgreens Gentle Laxative 10 mg 00363-0466-04 Walgreens 40 mg — — FDA listed —
Walgreens Gentle Laxative 10 mg 00363-0468-04 Walgreens 4 suppositories — — FDA listed —
Rite-Aid Gentle Laxative 10 mg 11822-4890-05 RITE 8 suppositories — — FDA listed —
Gentle Laxative Bisacodyl 10 mg 13709-0321-01 NeilMed 30 capsules — — FDA listed —
Bisacodyl Laxative 10 mg/1.8g 13709-0328-01 Neilmed 1.8 g — — FDA listed —
HEB Gentle Laxative 10 mg/2000mg 37808-0877-08 H 40 mg — — FDA listed —
Dulcolax Laxative 10 mg 41167-0210-01 Chattem, 4 suppositories — — FDA listed —
Meijer Gentle Laxative 10 mg/2000mg 41250-0665-04 Meijer 40 mg — — FDA listed —
Discount Drugmart Gentle Laxative 10 mg/2000mg 53943-0805-08 Discount 40 mg — — FDA listed —
Dollar General Gentle Laxative 10 mg/2000mg 55910-0457-04 Dolgencorp, 40 mg — — FDA listed —
Bisacodyl 10 mgthis 57896-0443-01 GERI-CARE 100 suppositories — — FDA listed —
Stratuscare Bisacodyl 10 mg 58980-0415-04 Stratus 4 suppositories — — FDA listed —
CVS Gentle Laxative 10 mg 59779-0107-09 CVS 8 suppositories — — FDA listed —
Bisacodyl 10 mg 68016-0084-08 Pharmacy 8 suppositories — — FDA listed —
Bisacodyl 10 mg 69842-0816-04 CVS 4 suppositories — — FDA listed —
Laxative 10 mg 70795-1010-01 GRAXCELL 100 suppositories — — FDA listed —
OneLAX 10 mg 71399-8460-02 AKRON 12 suppositories — — FDA listed —
Conlax 10 mg 72701-0102-04 Bliss 4 suppositories — — FDA listed —
Bisacodyl 10 mg 82568-0028-02 AARNA 12 suppositories — — FDA listed —
Bisacodyl 10 mg 83720-0550-25 Oncor 12 suppositories — — FDA listed —
Bisacodyl Laxative 10 mg 71457-0501-01 InvaDerm 102 suppositories — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2019
On the market since
Nov 2019
📍
2026
Currently FDA-listed
7 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color white
ShapeBullet
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 8334LX7S21
    A solid fat derived from animal or vegetable sources, used as a coating agent and lubricant to help pills slide smoothly during manufacturing and protect the medicine from moisture and air.

1 inactive ingredient listed in the exact product block matched to this NDC.

The official label also statesInactive ingredient hard fat

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerGERI-CARE PHARMACEUTICAL CORP
FDA application505G(a)(3) (OTC MONOGRAPH DRUG)
Labeler code57896
First marketedNov 2019
Product typeHuman Otc Drug
Portfolio45 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 17 words ▾

Uses relieves occasional constipation this product generally produces a bowel movement in 15 minutes to 1 hour

⏱️ Dosage and Administration 100 words ▾

Directions tear off one suppository from the strip peel apart the wrapper continue peeling apart to almost the full length of the suppository (see illustration at the right) gently remove the suppository from the wrapper lie on your side and push suppository, with pointed end first, high into the rectum so it will not slip out retain it for about 15 to 20 minutes. Do not exceed recommended dose if suppository seems soft, place in refrigerator for a short time before use adults and children 12 years and over 1 suppository once daily children under 12 years Ask a doctor

⚠️ Warnings 16 words ▾

Warnings For rectal use only Do not use when abdominal pain, nausea, or vomiting are present.

📦 Storage and Handling 12 words ▾

Other information store at temperatures below 25 C (77F) Made in India

🧪 Active Ingredient 9 words ▾

Active ingredient (in each suppository) Bisacodyl USP, 10 mg

🧪 Inactive Ingredients 4 words ▾

Inactive ingredient hard fat

🎯 Purpose 3 words ▾

Purpose Stimulant Laxative

📄 Do Not Use 11 words ▾

Do not use when abdominal pain, nausea, or vomiting are present.

📄 Ask a Doctor Before Use If 21 words ▾

Ask a doctor before use if you have a sudden change in bowel habits that lasts over a period 2 weeks.

📄 When Using This Product 14 words ▾

When using this product you may experience rectal burning mild cramps abdominal discomfort faintness

📄 Stop Use and Ask a Doctor If 42 words ▾

Stop use and ask a doctor if you have rectal bleeding or you fail to have bowel movement after using a laxative. These may be signs of a serious condition. you need to use a laxative product for more than one week

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 4 words ▾

Questions or Comments? 1-800-540-3765

📄 Package Label / Principal Display Panel 1 words ▾

1

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by GERI-CARE PHARMACEUTICAL CORP. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 12 suppositories (57896-0443-12), 50 suppositories (57896-0443-05). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
GERI-CARE PHARMACEUTICAL CORP is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 57896-0441-01 · Geri-Care 57896-0454-01 · Geri-Care →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.